Assistant Professor of Medicine, Harvard Medical School; Assistant Hospital Epidemiologist and Associate Director of Antimicrobial Stewardship Program, Brigham and Women's Hospital

Infectious Disease

Dr. Michael Calderwood, MD


Michael Calderwood practices Infectious Disease. He researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine Michael Calderwood has written publications. He has 18 publications published with PubMed. The lastest paper is: 'Impact of Hospital Operating Margin on Central Line-Associated Bloodstream Infections Following Medicare's Hospital-Acquired Conditions Payment Policy.' Michael Calderwood accepts Medicare payments and is listed with Medicare.gov.



Publications


Schools


Doctors Specialties


Accepted Insurances


Education


Hospital


Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1982756664
Last Name Of The Provider CALDERWOOD
First Name Of The Provider MICHAEL
View All

Similar Doctors


Dr. Michele Trucksis, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Anne L. Piantadosi, MD
This Doctor is OpenDoctor Recommended.
Dr. Douglas S. Kwon, MD
This Doctor is OpenDoctor Recommended.
Dr. Mary L. Pisculli, MD
This Doctor is OpenDoctor Recommended.
Dr. Yonatan Grad, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Peter F. Weller, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Christopher F. Rowley, MD
This Doctor is OpenDoctor Recommended.
Dr. Mary T. Lasalvia, MD
This Doctor is OpenDoctor Recommended.
Dr. Linden Hu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Jeffrey K. Griffiths, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Shira Doron, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Tine Vindenes, MD


Doctor Directory | TOS | twitter | FB | Angel | blog